Sha'ar Menashe Mental Health Center   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Hadera Israel (1949)

Organization Overview

First Clinical Trial
2005
NCT00174889
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Sha’ar Menashe Mental Health Center | Shaar Menashe MHC | Sha'ar Menshae Mental Health Center

Active Ingredients

Drugs in Phase 4 Trials (3)

baclofen (lioresal) (1 trial)

clozapine (clozaril) (1 trial)

pregnenolone (3 trials)

Drugs in Phase 3 Trials (2)

pyridoxine (1 trial)

theanine (2 trials)

Drugs in Other Trials (1)

fluvoxamine (luvox) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 4)

Disease (Phase 4)

Dyskinesias (Phase 3)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Tardive Dyskinesia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 6